The International AIDS conference, that takes place every two years, is the opportunity for researchers to improve their knowledge regarding a large HIV scope, meet with other researchers and stakeholders in the fight against HIV, including community representatives, to discuss priorities of HIV research and strengthen collaborations as well as present their results. In 2018, several researchers from the IDLIC team presented their research results.
Thierry Tiendrebeogo (PhD student) presented two posters on studies conducted in Abidjan, Côte d’Ivoire. The first one (#4841), based on the ANRS 12136 Temprano trial, showed that early HIV treatment initiated before pregnancy was not associated with adverse pregnancy outcomes (stillbirths, small for gestational age, preterm delivery and low birthweight) and thus reassured while since 2015, the WHO recommendation being implemented worldwide, is universal and immediate HIV treatment in all people living with HIV regardless of their clinical or biological status. The second one (#1179), written by Carole Chedid (trainee from ENS Lyon), highlighted the high prevalence of sexually transmitted infection (STI) among HIV-positive women on HIV treatment within the WETIV-R cohort, and thus the need to integrate STI management into HIV care as well as target their male partners to ensure treatment efficacy.
Several abstracts were also presented on the ANRS 12249 TasP trial, conducted in rural South Africa where HIV prevalence is about 30%. Joanna Orne-Gliemann (social sciences researcher) did an oral presentation at a symposium (#101) introducing the consortium on the Test and Treat trials for HIV prevention in southern and eastern Africa. Mélanie Plazy (public health and epidemiology researcher) presented one poster (#10158) on the acceptability and efficacy of repeat home-based HIV testing as a strategy to contribute to reach universal HIV testing in high HIV prevalence settings. Joseph Larmarange (demography researcher at IRD, Paris) did an oral presentation showing that universal HIV testing and treatment could increase population viral suppression over time, but that more efforts are needed to improve linkage to care after an HIV diagnosis.
To see the related abstracts :
- Tiendrebeogo et al: http://programme.aids2018.org/Abstract/Abstract/1179
- Chedid et al: http://programme.aids2018.org/Abstract/Abstract/4841
- Plazy et al: http://programme.aids2018.org/Abstract/Abstract/10158
- Orne-Gliemann et al: http://programme.aids2018.org/Programme/Session/101
- Larmarange et al: http://programme.aids2018.org/Abstract/Abstract/3415